Trademarkia Logo

Canada

C$
Trademark Search in Canada
DELIX THERAPEUTICS

View On IC.GC.CA

DELIX THERAPEUTICS
ADVERTISED

on 9 Apr 2025

Last Applicant/ Owned by

Delix Therapeutics, Inc.

20 Authors RoadConcord, MA 01742

US

Serial Number

2139110 filed on 8th Oct 2021

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

DELIX THERAPEUTICS

Trademark usage description

pharmaceutical products for the treatment of mental health conditions, namely, depression, anxiety, mood disorders, post-traumatic stress, cognitive Read More

Classification Information

Class [005]
Pharmaceutical products for the treatment of mental health conditions, namely, depression, anxiety, mood disorders, post-traumatic stress, cognitive and neurodegenerative diseases and disorders; pharmaceutical products in the fields of mental health diseases and disorders, namely depression, anxiety, mood disorders, post-traumatic stress, cognitive and neurodegenerative diseases and disorders

Classification kind code

11

Class [042]
Pharmaceutical research and development; drug discovery services; laboratory research services relating to pharmaceuticals, namely, research in the fields of health and mental health diseases and disorders

Classification kind code

11

Mark Details

Serial Number

2139110

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 42
on 9th Apr 2025		Advertised
Submitted for opposition 27
on 10th Mar 2025		Approval Notice Sent
Submitted for opposition 26
on 10th Mar 2025		Approved
Submitted for opposition 22
on 9th Jan 2025		Search Recorded
Submitted for opposition 20
on 9th Jan 2025		Examiner's First Report
Submitted for opposition 287
on 11th Jul 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 8th Oct 2021		Filed
Submitted for opposition 1
on 8th Oct 2021		Created
Submitted for opposition 31
on 8th Oct 2021		Formalized